No added heart risk from heartburn drugs

  1. The FDA and its Canadian counterpart began reviewing the drugs, used by tens of millions of people, back in May. The drug's manufacturer, AstraZeneca PLC, provided an early analysis of two small studies that suggested the possibility of a risk. The agency said its review of that study as well as 14 others indicated no increased risk for patients.
  2. Visit bethin profile page

    About bethin

    Joined: Sep '05; Posts: 7,767; Likes: 1,230


  3. by   EmmaG
    I'll stick with Tums, thanks.
  4. by   gigabytes
    An advance Merry Christmas to those who celebrate christmas n happy new year!!!